The present application relates to novel 4-(4-cyano-2-thioaryl)dihydro-pyrimidin-2-one derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of disorders, and to the use thereof for production of medicaments for treatment and/or prevention of disorders, especially for treatment and/or prevention of disorders of the lung and of the cardiovascular system.